Journey to Expertise
Education
Specialized training at Reus University Hospital and Barcelona Clinical Hospital;
Completion of specialist training at Pitié-Salpêtrière Hospital in Paris.
Shortly About
Dr. Ricardo Yaya Tur
Dr. Ricardo Yaya Tur stands as a highly esteemed oncologist in Spain, renowned for his extensive experience and remarkable success in the field of medical oncology. With 23 years of dedicated practice, Dr. Yaya Tur has established himself as a leading expert, particularly excelling in the treatment and research of Central Nervous System cancers, encompassing tumors of the brain and spinal cord. His specialization extends to digestive system cancers, focusing on conditions such as oesophageal, stomach, pancreatic, bile duct, and liver cancer. Dr. Yaya Tur's journey to becoming a distinguished medical oncologist includes specialized training at Reus University Hospital and Barcelona Clinical Hospital. He further honed his expertise at the prestigious Pitié-Salpêtrière Hospital in Paris, solidifying his commitment to advancing cancer care. Fluent in English, French, and Spanish, Dr. Yaya Tur bridges language gaps to provide comprehensive and patient-centered oncological care. As a testament to his dedication to the field, he is an active member of several scientific societies, including the Spanish Society of Medical Oncology (SEOM), Spanish Digestive Cancer Research Group (GEMCAD), French Neuro-Oncology Association (ANOCEF), and Spanish Neuro-Oncology Association (GEINO). Dr. Yaya Tur's contributions extend beyond clinical practice, with numerous research articles published in renowned international medical journals. Since 1997, he has been a pivotal member of the Valencian Oncology Institute, where his expertise continues to positively impact the lives of patients facing various forms of cancer.
Spotlight on Success
Awards & Achievement
Recognition for extensive experience and success in the field of medical oncology.
Elite Affiliations
Professional Membership
Member of the Spanish Society of Medical Oncology (SEOM);
Member of the Spanish Digestive Cancer Research Group (GEMCAD);
Member of the French Neuro-Oncology Association (ANOCEF);
Member of the Spanish Neuro-Oncology Association (GEINO).